This finding was also observed in a recent meta-analysis, where Ren et al. showed that the use of statins can reduce inflammatory markers of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), as well as alleviate the disease activity and symptoms of RA patients [53]. This evidence concerns the gene CRP and rheumatoid arthritis.